Submitted by Anonymous (not verified) on 28 August 2023 - 15:20
Human medicines European public assessment report (EPAR): Enjaymo, sutimlimab, Hemolysis;Anemia, Hemolytic, Autoimmune, Date of authorisation: 15/11/2022, Revision: 3, Status: Authorised
Source: